The following is a summary of "Bronchiectasis In Patients With Inflammatory Bowel Diseases – Prevalence, Predictors, And ...

The article titled "Effects of the DPP-1 Inhibitor HSK31858 in Adults with Bronchiectasis in China (SAVE-BE): A Phase 2, Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial," focuses on ...

DPP1 inhibitor brensocatib has been submitted for approval by the FDA for non-cystic fibrosis bronchiectasis based on the results of the ASPEN trial, which showed that the drug cut the number of ...

Percent-predicted FEV1 measured before pregnancy did not fall 1 year after in women with highly effective cystic fibrosis ...

【Translation】 According to the CDE website, HSK31858, a Class 1 new drug, was included in the breakthrough therapy designation in 2024 for non-cystic fibrosis bronchiectasis, becoming the ...

Cystic fibrosis (CF ... leading to chronic infections and bronchiectasis with resulting marked decline in pulmonary function. The only treatment for end-stage CF lung disease is lung transplantation.

Considering taking supplements to treat bronchiectasis? Below is a list of common natural remedies used to treat or reduce the symptoms of bronchiectasis. Follow the links to read common uses ...

Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Murray et al, Eur Respir J 2009, DOI: 10.1183/09031936.00163208 Colour of phlegm can predict outcomes for patients with ...

Find effective medications for 'Bronchiectasis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...

To participate, please dial one of the following numbers and ask to join the Verona Pharma call: A live webcast will be available on the Events and Presentations link on the Investors page of the ...